Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL)

    • Cancer
    • Non Hodgkin Lymphoma (NHL)
    • Diffuse Large B-Cell Lymphoma (DLBCL)